Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery

References

• Agnihotri SM, Vavia PR. (2009). Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine, 5, 90–95.
   PubMed Web of Science ®Google Scholar
• Araújo J, Vega E, Lopes C, Egea MA, Garcia ML, Souto EB. (2009). Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces, 72, 48–56.
   PubMed Web of Science ®Google Scholar
• Bochot A, Fattal E, Grossiord JL, Puisieux F, Couvereur P. (1998). Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int J Pharm, 162, 119–127.
   Web of Science ®Google Scholar
• Chaiarini A, Tartarini A, Fini A. (1984). pH solubility relationship and partition coefficient for some anti-inflammatory arylaliphatic acid. Arch Pharm, 317, 268–273.
   Web of Science ®Google Scholar
• De Campos AM, Diebold Y, Carvaiho ELS, Sanchez A, Alonso MJ. (2004) Chitosan nanoparticles as new ocular drug delivery system: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res, 21, 803–810.
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sánchez A, Gref R, Calvo P, Alonso MJ. (2003). The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci, 20, 73–81.
   PubMed Web of Science ®Google Scholar
• Ding S. (1998). Recent developments in ophthalmic drug delivery. Pharm Sci Technol Today, 1, 328–335.
   Google Scholar
• Duffy MT, Bloom JN, McNally-Heintzelman KM, Heintzelman DL, Soller EC, Hoffman GT. (2005). Sutureless ophthalmic surgery: a scaffold-enhanced bioadhesive technique. J AAPOS, 9, 315–320.
   PubMed Web of Science ®Google Scholar
• Ewers R, Lieb-Skowron J. (1990). Bioabsorbable osteosynthesis materials. Facial Plast Surg, 7, 206–214.
   PubMedGoogle Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. (1999). PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release, 57, 171–185.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. (2009). Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine, 6, 324–333.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Chander P. (2010). A Single RP-UPLC method for quantification of Levofloxacin in aqueous humour and pharmaceutical dosage forms. J Chromatogra Sci, 48, 484–490.
   PubMed Web of Science ®Google Scholar
• Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. (2007). Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv, 14, 507–515.
   PubMed Web of Science ®Google Scholar
• Jain RA. (2000). The manufacturing techniques of various drug-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 21, 2475–2490.
   PubMed Web of Science ®Google Scholar
• Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM. (2007). Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm, 340, 126–133.
   PubMed Web of Science ®Google Scholar
• Keating GM. (2009). Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery. Drugs, 69, 1267–1286.
   PubMed Web of Science ®Google Scholar
• Losa C, Calvo P, Castro E, Vila-Jato JL, Alonso MJ. (1991). Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol, 43, 548–552.
   PubMed Web of Science ®Google Scholar
• Losa C, Marchal-Heussler L, Orallo F, Vila Jato JL, Alonso MJ. (1993). Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm Res, 10, 80–87.
   PubMed Web of Science ®Google Scholar
• Mandal B, Halder KK, Dey SK, Bhoumik M, Debnath MC, Ghosh LK. (2009). Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release. Pharmazie, 64, 445–449.
   PubMed Web of Science ®Google Scholar
• Marchal Heussler L, Fessi H, Devissaguet JP, Hoffman M, Maincent P. (1992). Colloidal drug delivery systems for eye: a comparison of the efficacy of three different polymers. S.T.P. Pharma Sciences, 2, 98–104.
   Google Scholar
• McCarron PA, Marouf WM, Quinn DJ, Fay F, Burden RE, Olwill SA, Scott CJ. (2008). Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. Bioconjug Chem, 19, 1561–1569.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Rawat MK, Mishra A, Singh S. (2009). PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine, 5, 323–333.
   PubMed Web of Science ®Google Scholar
• Paolicelli P, Cerreto F, Cesa S, Feeney M, Corrente F, Marianecci C, Casadei MA. (2008). Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs. J Microencapsul, 25, 1–10.
   PubMed Web of Science ®Google Scholar
• Pleyer U, Lutz S, Jusko W, Nguyen K, Narawane M, Rückert D, Mondino BJ, Lee VH. (1993). Ocular absorption of topically applied FK506 from liposomal and oil formulations in rabbit eye. Invest Ophthalmol Vis Sci, 34, 2737–2742.
   PubMed Web of Science ®Google Scholar
• Schoenwald RD, Stewart P. (1980). Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci, 69, 391–394.
   PubMed Web of Science ®Google Scholar
• Reis CP, Ribeiro AJ, Veiga F, Neufeld RJ, Damgé C. (2008). Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv, 15, 127–139.
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. (2001). Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 71, 53–69.
   PubMed Web of Science ®Google Scholar
• Spielmann H. (1997). Ocular irritation. In: Castle JV, Gomez MJ, eds. In Vitro Methods in Pharmaceutical Research (pp. 265–87). San Diego, CA: Academic Press.
   Google Scholar
• Sultana Y, Aqil M, Ali A. (2006). Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops. Drug Deliv, 13, 215–219.
   PubMed Web of Science ®Google Scholar
• Suri SS, Fenniri H, Singh B. (2007). Nanotechnology-based drug delivery systems. J Occup Med Toxicol, 2, 16.
   PubMedGoogle Scholar
• Surti N, Naik S, Bagchi T, Dwarkanath BS, Misra A. (2008). Intracellular delivery of nanoparticles of an antiasthmatic drug. AAPS PharmSciTech, 9, 217–223.
   PubMed Web of Science ®Google Scholar
• Vega E, Gamisans F, García ML, Chauvet A, Lacoulonche F, Egea MA. (2008). PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci, 97, 5306–5317.
   PubMed Web of Science ®Google Scholar